MetLife, Inc. (NYSE:MET) Stock Position Trimmed by SeaCrest Wealth Management LLC

SeaCrest Wealth Management LLC cut its position in MetLife, Inc. (NYSE:METFree Report) by 8.2% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,364 shares of the financial services provider’s stock after selling 389 shares during the quarter. SeaCrest Wealth Management LLC’s holdings in MetLife were worth $350,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the company. Norges Bank bought a new stake in MetLife during the 4th quarter valued at $730,716,000. Price T Rowe Associates Inc. MD raised its stake in shares of MetLife by 33.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 24,663,239 shares of the financial services provider’s stock valued at $2,019,427,000 after purchasing an additional 6,213,923 shares in the last quarter. Bank of New York Mellon Corp raised its stake in shares of MetLife by 109.2% during the fourth quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider’s stock valued at $722,727,000 after purchasing an additional 4,606,748 shares in the last quarter. Clearbridge Investments LLC raised its stake in shares of MetLife by 43.7% during the fourth quarter. Clearbridge Investments LLC now owns 5,663,177 shares of the financial services provider’s stock valued at $463,701,000 after purchasing an additional 1,723,461 shares in the last quarter. Finally, Northern Trust Corp raised its position in shares of MetLife by 15.7% during the 4th quarter. Northern Trust Corp now owns 7,052,202 shares of the financial services provider’s stock worth $577,434,000 after buying an additional 958,458 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

MET has been the topic of a number of recent analyst reports. Wells Fargo & Company boosted their price target on shares of MetLife from $91.00 to $94.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 6th. Wall Street Zen cut MetLife from a “buy” rating to a “hold” rating in a report on Saturday, May 24th. Morgan Stanley boosted their price objective on MetLife from $94.00 to $99.00 and gave the stock an “overweight” rating in a research note on Monday, May 19th. Barclays dropped their price objective on MetLife from $95.00 to $88.00 and set an “overweight” rating on the stock in a research note on Friday, April 11th. Finally, UBS Group boosted their price target on shares of MetLife from $94.00 to $98.00 and gave the stock a “buy” rating in a research report on Wednesday, April 2nd. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat, MetLife presently has a consensus rating of “Moderate Buy” and a consensus price target of $94.17.

View Our Latest Report on MET

MetLife Stock Up 1.8%

Shares of MetLife stock opened at $79.99 on Friday. The stock’s fifty day moving average is $76.15 and its 200-day moving average is $80.86. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54. The firm has a market capitalization of $53.70 billion, a PE ratio of 13.40, a price-to-earnings-growth ratio of 0.65 and a beta of 0.86. MetLife, Inc. has a 12-month low of $65.21 and a 12-month high of $89.05.

MetLife (NYSE:METGet Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.96 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.00 by ($0.04). MetLife had a return on equity of 20.42% and a net margin of 6.19%. The company had revenue of $18.57 billion for the quarter, compared to analyst estimates of $18.06 billion. During the same quarter in the previous year, the firm posted $1.83 EPS. MetLife’s quarterly revenue was up 15.6% on a year-over-year basis. Equities analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 10th. Investors of record on Tuesday, May 6th will be paid a $0.5675 dividend. This is a positive change from MetLife’s previous quarterly dividend of $0.55. The ex-dividend date of this dividend is Tuesday, May 6th. This represents a $2.27 dividend on an annualized basis and a yield of 2.84%. MetLife’s dividend payout ratio (DPR) is currently 36.91%.

MetLife announced that its Board of Directors has approved a stock buyback program on Wednesday, April 30th that allows the company to repurchase $3.00 billion in shares. This repurchase authorization allows the financial services provider to buy up to 5.9% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s leadership believes its stock is undervalued.

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

See Also

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.